The National Institutes of Health's $1 billion RECOVER Initiative has decided to study Pfizer Inc's (NYSE: PFE) antiviral drug Paxlovid as a potential treatment for long COVID.
Pfizer Inc (NYSE: PFE) came forward to defend a lawsuit by a group of medical professionals claiming that the fellowship program illegally excludes whites and Asian Americans.
HYPER-H21-4 using DehydraTECH-CBD evidenced:
Exceptional safety and tolerability
Statistically significant lowering of 24-hour ambulatory blood pressure ("BP")
BP lowered for the entire 5-week study
Stevanato Group aims to expand distribution of EZ-fill® whose proven advantages have turned its processing technology into an industry standard for Ready-To-Use products.
Stevanato Group S.p.A. (NYSE:STVN), a
– Using Invitae's Ciitizen patient-driven data platform, AstraZeneca and the Cholangiocarcinoma Foundation will access lived experience of patients with a rare cancer to drive further research –
–
Emerging infectious diseases where no protective vaccines are currently available
SuVax™ targets Sudan ebolavirus, origin of a current disease outbreak in Uganda